The PCL COVID19 Rapid FIA Test is an in vitro diagnostic medical device applying sandwich fluorescent immunoassay to qualitatively detect SARS CoV 2 antigen in human oropharyngeal /nasopharyngeal specimens and sputum specimens.
- 10 min Qualitative detection of SARS CoV 2 Antigens
- Human oropharyngeal swabs and deep sputum samples
- POCT Analyzer Provided
PCL COVID19 Rapid FIA Test is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy PCL COVID19 Rapid FIA Test for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the PCL COVID19 Rapid FIA Test or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the PCL COVID19 Rapid FIA Test or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
